About Shreepati Molecules Private Limited
Data last updated:
Shreepati Molecules Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24290MP2017PTC043280. Its GSTIN is 23AAYCS6369K1ZF (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Rajesh Muchhal and Kishor Rajaram Thakur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 208 Silver Arc Plaza 20/1 New Palasia, Indore, Madhya Pradesh, India – 452001.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shreepatimolecules.com.
Company details
Contact details
Shreepati Molecules Private Limited's registered office is in Indore, Madhya Pradesh. Its website is shreepatimolecules.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address208 Silver Arc Plaza 20/1 New Palasia, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Shreepati Molecules Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Shreepati Molecules Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shreepati Molecules Private Limited, buy the company report.
Board of directors of Shreepati Molecules Private Limited
Shreepati Molecules has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Muchhal Also directs: Shreepati Pharmaceuticals Pvt Ltd | Director | 11 May 2017 | 9 Years 5 Months | Current |
| Kishor Rajaram Thakur Also directs: Synthetic Molecules Private Limited | Director | 11 May 2017 | 9 Years 5 Months | Current |
| Akshay Thakur | Director | 22 May 2025 | 1 Years 5 Months | Current |
| Ravi Muchhal Also directs: Shreepati Pharmaceuticals Pvt Ltd | Director | 11 May 2017 | 9 Years 5 Months | Current |
Auditor
Shreepati Molecules Private Limited is audited by AVINASH AGRAWAL AND COMPANY for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AVINASH AGRAWAL AND COMPANY | FY 2022 | 0022666C |
Shareholding
The shareholding of Shreepati Molecules Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Shreepati Molecules Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Shreepati Molecules Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shreepati Molecules Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shreepati Molecules has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAYCS6369K1ZF | Madhya Pradesh | Active | 18 Aug 2017 |
To see the full GST registrations and return filing status of Shreepati Molecules Private Limited, buy the company report.
Recent activity
Shreepati Molecules Private Limited has 4 board changes on record since 2017: 4 appointments. The latest: Akshay Thakur was appointed as Director on 22 May 2025.
Frequently asked questions
Shreepati Molecules is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 May 2017 (9+ years old) and is registered under CIN U24290MP2017PTC043280.
Shreepati Molecules has 4 current directors:
- Rajesh Muchhal - Director
- Kishor Rajaram Thakur - Director
- Akshay Thakur - Director
- Ravi Muchhal - Director
The latest financial statements of Shreepati Molecules on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Shreepati Molecules is 23AAYCS6369K1ZF, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Shreepati Molecules is U24290MP2017PTC043280. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shreepati Molecules was incorporated on 11 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Gwalior.
Akshay Thakur was appointed as Director on 22 May 2025. Kishor Rajaram Thakur was appointed as Director on 11 May 2017. Rajesh Muchhal was appointed as Director on 11 May 2017. Shreepati Molecules has 4 board changes on record in total.
Shreepati Molecules can be reached through the website shreepatimolecules.com. Its registered office is in Indore, Madhya Pradesh, India.
The registered office of Shreepati Molecules is at 208 Silver Arc Plaza 201 New Palasia, Indore, Madhya Pradesh, India – 452001.
Shreepati Molecules operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
